drugset / Trial / NCT03286205

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

NCT03286205 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.

Timeline

Start
2015-04-14
Primary completion
2018-08-31
Completion
2018-08-31

Outcome

Outcome not reported

Stopped: “IP unavailable at site.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron dextrose Unknown 100 mg Intravenous